HOE T3 Mycin 1.2% Lotion

HOE T3 Mycin 1.2% Lotion is a topical antibiotic preparation containing clindamycin phosphate 1.2% as its active ingredient. It is prescribed by doctors for the treatment of mild to moderate inflammatory acne vulgaris, where it works by reducing the population of acne-causing bacteria (Cutibacterium acnes, formerly Propionibacterium acnes) on the skin and helping to reduce the associated inflammation, redness, and swelling of acne lesions.

As a prescription-only medicine, HOE T3 Mycin 1.2% Lotion requires an online consultation with a doctor through DoctorOnCall before it can be dispensed, so that your acne can be properly assessed, an appropriate treatment plan (which may include combination therapy) can be recommended, and you can be monitored for response and possible side effects such as skin irritation.

Clindamycin is a lincosamide antibiotic that works by inhibiting bacterial protein synthesis, which reduces the number of Cutibacterium acnes bacteria within hair follicles and sebaceous glands; by lowering bacterial activity and the inflammatory by-products they produce, clindamycin helps reduce the redness, swelling, and number of inflammatory acne lesions such as papules and pustules.

Apply a thin layer of HOE T3 Mycin 1.2% Lotion to clean, dry, affected skin as directed by your doctor, usually once or twice daily, avoiding the eyes, lips, and mucous membranes; wash your hands after application unless the hands are the area being treated.

The frequency and duration of use of HOE T3 Mycin 1.2% Lotion should be determined by your prescribing doctor based on the severity of your acne and your response to treatment; visible improvement typically takes several weeks of consistent use, and treatment courses are often continued for a number of months under medical follow-up.

Use HOE T3 Mycin 1.2% Lotion within the expiry date printed on the packaging, and discontinue use once this date has passed.

Store below 30°C in a cool, dry place away from direct sunlight, keep the container tightly closed, and keep out of reach and sight of children.

Clindamycin Topical

Clindamycin

• Known hypersensitivity to clindamycin, lincomycin, or any ingredient in the product
• History of antibiotic-associated colitis (e.g., pseudomembranous colitis) linked to clindamycin or lincomycin
• Regional enteritis or ulcerative colitis, unless specifically cleared by a doctor
• Use on broken, sunburned, or severely irritated skin without medical advice

• Avoid concurrent use with other topical acne products containing strong exfoliants (e.g., high-strength benzoyl peroxide, retinoids) without medical guidance, as this may increase skin irritation
• Neuromuscular blocking agents may have their effects enhanced by clindamycin; relevant mainly in a hospital or anaesthesia setting, but should be disclosed to any treating doctor
• No significant food interactions are established for topical clindamycin

• Apply to clean, dry skin for best absorption and effect
• Be patient; visible improvement in acne can take 4 to 8 weeks of consistent use
• Avoid combining with other irritating topical products unless directed by your doctor, to reduce the risk of excessive dryness or irritation
• Use sun protection, as treated skin may be more sensitive to sunlight
• Contact your doctor if you develop severe diarrhoea, as this may indicate a rare but serious reaction

Clindamycin Topical

Clindamycin

HOE T3 Mycin 1.2% Lotion is intended for use under medical supervision, often as part of a combination acne treatment plan, since using a topical antibiotic alone over a prolonged period may increase the risk of antibiotic resistance. Your doctor may periodically review your treatment and adjust it based on your progress.